Akrimax Pharmaceuticals Announces Manufacturing P...(ufacturing distribution and commercializ...),Health

Date:1/6/2009

ufacturing, distribution, and commercialization of a full range of top-quality pharmaceutical products. Akrimax currently markets Inderal(R) LA and LoOvral(R) branded products and operates the manufacturing facility in conjunction with Wyeth during a transition period that runs through 2009. www.Akrimax.com

    For more information
    Timothy Soule: tsoule@akrimax.com
    Kevin Ellis: Kimbell Sherman Ellis: 800-498-5390 ext. 107:
    Kevin@kse50.com

'/>"/>

SOURCE Akrimax Pharmaceuticals, LLC Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
2. Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
3. AUDIO from Medialink and Solvay Pharmaceuticals: New Initiative Urges Women to Address Mens Health this New Year
4. Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
5. Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
6. Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
7. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
8. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
9. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
10. Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis
11. SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth Pharmaceuticals